BiotechTube
Home/MAIA Biotechnology/Sergei M. Gryaznov, PhD
SM

Sergei M. Gryaznov, PhD

Chief Scientific Officer

MAIA Biotechnology

Therapeutic Areas

Oncology

MAIA Biotechnology Pipeline

DrugIndicationPhase
Ateganosine (THIO)Non-Small Cell Lung Cancer (NSCLC)Phase 2
Second-generation telomere targeting agentsCancerPre-clinical/Research

Leadership Team at MAIA Biotechnology

VV
Vlad Vitoc, MD, MBA
Chief Executive Officer and Chairman
JC
Jeffrey C. Himmelreich
Head of Finance
View full MAIA Biotechnology profile